CClinicalTrials.gg
RecruitingNCT05674409B-FITUpdated Feb 5, 2026

Brief Family Involved Treatment Telehealth

An interventional study of Brief Family-Involved Treatment (B-FIT) and Cognitive Behavioral Therapy for Alcohol Use Disorder (CBT for AUD) in Alcohol Use Disorder, sponsored by Medical University of South Carolina. Recruiting at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-02-05.

Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2023; still recruiting 3 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

Improving alcohol use disorder (AUD) treatment among Veterans is a national public health problem. The rate of AUD among Veterans is twice that of civilians, with up to 50% of Veterans having AUD. Family-based AUD programs are rarely undertaken in busy treatment clinics, and Veterans with problem drinking behavior or AUD are commonly excluded from couple therapies. As a result, there is a need to develop effective family AUD treatments that are both brief and highly accessible to Veterans.

The purpose of this study is to evaluate a new treatment add-on called Brief Family-Involved Treatment (B-FIT), which will be delivered via telehealth among Veterans engaged in alcohol-based treatment/therapy.

This study is an 12-week, Stage-II, open randomized controlled trial examining B-FIT in combination with treatment as usual (TAU), (in this case B-FIT+ Cognitive Behavioral Therapy treatment) as compared to TAU alone (CBT treatment).Veterans and their treatment companion (family member, partner, friend) will complete weekly assessments during the treatment phase in addition to 3 \& 6 month follow-up assessments, all via telehealth.

Read the detailed description

Improving alcohol use disorder (AUD) treatment among Veterans is a national public health priority. The prevalence of AUD among Veterans is twice that of civilians, with up to 50% of Veterans meeting diagnostic criteria for lifetime AUD. Although one in 6 Veterans has an AUD diagnosis in their medical record, substantial barriers to accessing evidence-based AUD treatment persists in this population. While adaptive family support is a critical ingredient to effective AUD treatment and drinking reductions, maladaptive family functioning interferes with AUD recovery and is a precipitant of relapse. Family participation in AUD treatment has the ability to optimize engagement and outcomes.

Family-based AUD programs are rarely undertaken in busy treatment clinics, and Veterans with problem drinking behavior or AUD are commonly excluded from couple therapies. There is an urgent need to develop efficacious family AUD treatments that are both brief and highly accessible to Veterans. Brief Family-Involved Treatment (B-FIT) delivered via telehealth is an intervention distilled from the robustly evidence-based Alcohol Behavioral Couple Therapy (ABCT) model. Designed to be implemented in combination with any existing alcohol treatment program, the goals of B-FIT are to (1) increase reinforcement for AUD treatment engagement, (2) increase positive rewards from drinking reductions, and (3) decrease drinking cues by decreasing negative communication and increasing positive communication.

The objective of the proposed Stage II study is to evaluate the efficacy of B-FIT delivered via telehealth among Veterans enrolled manualized treatment for AUD (Cognitive Behavioral Therapy, CBT). We will also examine putative individual and family characteristics that mediate treatment outcomes. To accomplish this, we will employ an open randomized controlled design and examine standardized, repeated, dependent measures of change. Veterans and a family member (or concerned partner/friend) will be randomly assigned (matched on age, sex and baseline alcohol consumption) to receive B-FIT in combination with TAU (CBT) or TAU alone. A total of 200 veterans and their treatment companions will be enrolled in this study (N=400).

02

Conditions studied

  • Alcohol Use Disorder

Browse trials for

03

In context

Alcoholism

1,606 studies on the registry are indexed under Alcoholism; 329 are open to participants now.

This study's planned enrollment of 400 is above the median of 87 across 1,371 interventional studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

Medical University of South Carolina is the lead sponsor of 852 studies on the registry; 165 are open to participants now.

Of its 128 completed or terminated interventional studies of FDA-regulated products, 101 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Participants will be 200 Veterans and a family member, plus their treatment companion, a concerned partner or friend (total N=400; 50% women veterans) aged 21 or older.

Inclusion criteria for Veterans require that they:

  1. Meet diagnostic criteria for current moderate to severe alcohol use disorder (AUD) with 2 or more heavy drinking days (>5 for men, >4 for women) in the 60 days prior to enrollment
  2. Have an adult family member/treatment companion who is willing to participate
  3. Demonstrate cognitive functioning sufficient to provide informed consent and participate accurately (≥ 26 on the Mini-Mental Status Exam [MMSE])
  4. Maintain a stable dose of psychotropic medications for at least 4 weeks before enrollment. Concurrent drug use disorders are acceptable provided alcohol is the Veteran's primary substance of choice. Drug use will be measured weekly and controlled for in statistical analyses if needed.

Inclusion criteria for the family member/treatment companion require that they:

  1. Are not receiving or seeking treatment for their own alcohol or drug problem
  2. Report total Alcohol Use Disorders Identification Test (AUDIT) scores \<8
  3. Report total Drug Abuse Screening Test (DAST-10) scores \<3.

Exclusion Criteria:

Exclusion criteria for all participants include:

  1. History of or current psychotic or bipolar disorder
  2. Alcohol withdrawal (Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) score >8)
  3. Current suicidal or homicidal ideation and intent
  4. Severe or unilateral violence in the past 6 months as measured by the Revised Conflict Tactics Scale (CTS2) (consistent with extant dyadic treatment literature).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Cognitive Behavioral Therapy + Brief Family-Involved Treatment

    Approximately half of enrolled veterans and their treatment companion will be randomly assigned to the experimental group. The identified veteran participant wil receive 12 sessions of Cognitive Behavioral Therapy for Alcohol Use Disorder (CBT for AUD). In addition, both the identified veteran and their treatment companion will receive an additional 3 sessions of Brief Family-Involved Treatment (B-FIT). B-FIT is a manualized, 3-session AUD intervention, designed to be implemented in combination with any existing alcohol treatment program.

    Behavioral: Brief Family-Involved Treatment (B-FIT) · Behavioral: Cognitive Behavioral Therapy for Alcohol Use Disorder (CBT for AUD)

  • Active comparator
    Cognitive Behavioral Therapy

    Approximately half of enrolled veterans and their treatment companion will be randomly assigned to the active comparator group. The identified veteran participant wil receive 12 sessions of Cognitive Behavioral Therapy for Alcohol Use Disorder (CBT for AUD).

    Behavioral: Cognitive Behavioral Therapy for Alcohol Use Disorder (CBT for AUD)

Interventions

  • BehavioralBrief Family-Involved Treatment (B-FIT)

    Brief Family-Involved Treatment (B-FIT) is a manualized, 3-session intervention for Alcohol Use Disorder (AUD). Designed to be implemented in combination with any existing alcohol treatment program, the goals of B-FIT are to (1) increase reinforcement for AUD treatment engagement, (2) increase positive rewards from drinking reductions, and (3) decrease drinking cues by decreasing negative communication and increasing positive communication.

  • BehavioralCognitive Behavioral Therapy for Alcohol Use Disorder (CBT for AUD)

    Participants will receive 12 sessions of Cognitive Behavioral Therapy for Alcohol Use Disorder (CBT for AUD).

06

What researchers measure

Primary outcomes

  1. Family functioning

    Change in family functioning as measured by the Brief Family Assessment Measure-III (Brief FAM-III)

    Time frame: From baseline to week 12

  2. Change in Alcohol Consumption

    Change in percent days abstinent, as measured by the Alcohol Timeline Followback (TLFB)

    Time frame: From baseline to week 12

  3. Change in percent days drinking

    Change in percent days drinking, as measured by the Alcohol Timeline Followback (TLFB)

    Time frame: From baseline to week 12

  4. Change in drinks per drinking day

    Change in drinks per drinking day , as measured by the Alcohol Timeline Followback (TLFB)

    Time frame: From baseline to week 12

  5. Alcohol problem severity

    Change in Alcohol problem severity as measured by the Alcohol Use Disorders Identification Test (AUDIT)

    Time frame: From baseline to week 12

  6. Change in alcohol craving

    Change in alcohol craving as measured by the Penn Alcohol Craving Scale (PACS)

    Time frame: From baseline to week 12

07

Study locations

1 of 1 sites recruiting
  • Medical University of South Carolina
    Charleston, South Carolina 29401, United States
    • Julianne Flanagan, PhD · Contact · hellmuth@musc.edu · 843-792-5569
    • Julianne Flanagan, Ph.D · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05674409
Lead sponsor
Medical University of South Carolina
Collaborators
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Responsible party
Julianne Flanagan (Associate Professor, Licensed Clinical Psychologist, Medical University of South Carolina) — Principal investigator
First posted
Jan 6, 2023
Start date
Mar 13, 2023
Primary completion
Mar 1, 2028 (estimated)
Completion
Mar 1, 2029 (estimated)
Last update
Feb 5, 2026

Study contacts

Stacey Sellers, MS
Contact
sellersst@musc.edu
843-792-5807
Julianne Flanagan, PhD
Contact
hellmuth@musc.edu
843-792-5569

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion